Streetbeat News

Products Services

VINO

Gaucho Holdings has announced the expansion of its business with the launch of the Gaucho Open Asset Lending Division. This new division aims to provide asset-backed loans, leveraging the company's existing assets to generate additional revenue streams.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 11:30 am

CDNA

CareDx will present new data at the 2024 American Transplant Congress, featuring 36 oral presentations and posters, and a symposium. The findings will highlight innovative approaches, including AI integration, and the clinical utility of CareDx's solutions in kidney, heart, and lung transplantation.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 11:28 am

CELC

Celcuity plans to initiate a Phase 3 clinical trial to evaluate Gedatolisib in combination with a CDK4/6 inhibitor and Fulvestrant. Additionally, the company has amended its existing debt facility agreement, securing an additional term loan of approximately $62 million.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 11:25 am

FBTC

GBTC

IBIT

Bitcoin spot ETFs have seen positive net inflows, with BlackRock's iShares Bitcoin Trust and Fidelity's Wise Origin Bitcoin Fund recording significant inflows. In contrast, Grayscale Bitcoin Trust experienced a notable outflow. Cathie Wood emphasized the political significance of cryptocurrency and ARK Invest's commitment to Bitcoin as a public good.

Portfolio Pulse from Murtuza Merchant

May 30, 2024 | 11:23 am

GANX

Gain Therapeutics announced that a late-breaking abstract with new data on GT-02287 has been accepted for presentation at the FENS Forum 2024.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 11:16 am

BLK

Trustly, a Swedish fintech firm backed by BlackRock Inc. (NYSE:BLK), reported a 51% increase in operating profit for 2023 but plans to delay its IPO for at least two years. The company saw significant growth in its U.S. operations and transaction volumes, but CEO Johan Tjarnberg emphasized the need to further demonstrate the value of its open banking technology to investors.

Portfolio Pulse from Benzinga Neuro

May 30, 2024 | 11:12 am

BLRX

BioLineRx announced a multi-center Phase 1 trial sponsored by St. Jude Children's Research Hospital to evaluate Motixafortide for CD34+ hematopoietic stem cell mobilization in gene therapy applications for sickle cell disease.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 11:11 am

SYTA

Siyata Mobile has been granted a new US patent for its VK7 vehicle kit, which could enhance its product offerings and market position.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 11:07 am

CGEN

Compugen will receive a $5 million milestone payment from AstraZeneca after dosing the first patient in the second Phase 3 trial of Rilvegostomig.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 11:06 am

BBW

Build-A-Bear Workshop reaffirms its fiscal 2024 outlook, expecting low-to-mid-single-digit revenue growth and mid-single-digit pre-tax income growth. The company plans to add at least 50 new experience locations and anticipates capital expenditures of $18-$20 million.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 10:50 am